Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Drebrin-like protein (DBNL) is a multifunctional actin-binding adaptor protein encoded by the DBNL gene in humans[1][5]. DBNL integrates cytoskeletal reorganization with diverse signaling processes, acting as a molecular bridge between actin dynamics and signal transduction pathways[1][2][3]. It binds actin filaments and localizes to the cytoplasm, intracellular organelles, and the plasma membrane; its localization is sensitive to the state of actin polymerization[2][4]. Phosphorylation of DBNL modulates stem-cell characteristics and supports cancer cell invasiveness, while its post-transcriptional regulation can influence metastatic potential and cell adhesion[1]. DBNL is critical in processes such as nervous system development, podosome assembly, sarcomere organization in muscle, and cell migration[1][4]. Dysregulation has been implicated in cancer proliferation, migration, and metastasis[1]. DBNL exists mainly as a dimer under physiological conditions and features distinct protein domains, including an ADF-H (actin depolymerizing factor-homology) domain, a coiled-coil region, a proline-rich region, and an SH3 domain[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Drebrin-like protein (DBNL).